-
Founded in:
1999-11-18 -
Country:
China -
Address:
No. 500, Juli Road, China (Shanghai) Pilot Free Trade Zone -
Tax NO.:
91310000607410671R -
Registered Funds:
$53 million -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pravastatin sodium |
This product is a competitive inhibitor of 3-hydroxy 3-methylglutaryl coenzyme A reductase (HMG-CoA reductase). It reduces the amount of intracellular cholesterol to a certain extent by reversibly inhibiting the activity of HMG-CoA reductase, leading to an increase in the number of low-density lipoprotein (LDL) receptors on the cell surface, thereby enhancing the receptor-mediated catabolism of LDL-C and the clearance of LDL-C in the blood; at the same time, it inhibits the synthesis of very low-density lipoprotein (VLDL-C) in the liver, thereby inhibiting the production of low-density lipoprotein (LDL-C).
More
This product is a competitive inhibitor of 3-hydroxy 3-methylglutaryl coenzyme A reductase (HMG-CoA reductase). It reduces the amount of intracellular cholesterol to a certain extent by reversibly inhibiting the activity of HMG-CoA reductase, leading to an increase in the number of low-density lipoprotein (LDL) receptors on the cell surface, thereby enhancing the receptor-mediated catabolism of LDL-C and the clearance of LDL-C in the blood; at the same time, it inhibits the synthesis of very low-density lipoprotein (VLDL-C) in the liver, thereby inhibiting the production of low-density lipoprotein (LDL-C). |
81131-70-6 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pravastatin sodium |
This product is a competitive inhibitor of 3-hydroxy 3-methylglutaryl coenzyme A reductase (HMG-CoA reductase). It reduces the amount of intracellular cholesterol to a certain extent by reversibly inhibiting the activity of HMG-CoA reductase, leading to an increase in the number of low-density lipoprotein (LDL) receptors on the cell surface, thereby enhancing the receptor-mediated catabolism of LDL-C and the clearance of LDL-C in the blood; at the same time, it inhibits the synthesis of very low-density lipoprotein (VLDL-C) in the liver, thereby inhibiting the generation of LDL-C.
More
This product is a competitive inhibitor of 3-hydroxy 3-methylglutaryl coenzyme A reductase (HMG-CoA reductase). It reduces the amount of intracellular cholesterol to a certain extent by reversibly inhibiting the activity of HMG-CoA reductase, leading to an increase in the number of low-density lipoprotein (LDL) receptors on the cell surface, thereby enhancing the receptor-mediated catabolism of LDL-C and the clearance of LDL-C in the blood; at the same time, it inhibits the synthesis of very low-density lipoprotein (VLDL-C) in the liver, thereby inhibiting the generation of LDL-C. |
81131-70-6 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pravastatin sodium |
It is a competitive inhibitor of 3-hydroxy 3-methylglutaryl coenzyme A reductase (HMG-CoA reductase). It reduces the amount of intracellular cholesterol to a certain extent by reversibly inhibiting the activity of HMG-CoA reductase, leading to an increase in the number of low-density lipoprotein (LDL) receptors on the cell surface, thereby enhancing the receptor-mediated degradation of LDL and the clearance of LDL in the blood; at the same time, it inhibits the synthesis of very low-density lipoprotein (VLDL-C) in the liver, thereby inhibiting the production of low-density lipoprotein cholesterol (LDL-C).
More
It is a competitive inhibitor of 3-hydroxy 3-methylglutaryl coenzyme A reductase (HMG-CoA reductase). It reduces the amount of intracellular cholesterol to a certain extent by reversibly inhibiting the activity of HMG-CoA reductase, leading to an increase in the number of low-density lipoprotein (LDL) receptors on the cell surface, thereby enhancing the receptor-mediated degradation of LDL and the clearance of LDL in the blood; at the same time, it inhibits the synthesis of very low-density lipoprotein (VLDL-C) in the liver, thereby inhibiting the production of low-density lipoprotein cholesterol (LDL-C). |
81131-70-6 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pravastatin sodium |
This product is a competitive inhibitor of 3-hydroxy 3-methylglutaryl coenzyme A reductase (HMG-CoA reductase). It reduces the amount of intracellular cholesterol to a certain extent by reversibly inhibiting the activity of HMG-CoA reductase, leading to an increase in the number of low-density lipoprotein (LDL) receptors on the cell surface, thereby enhancing the receptor-mediated catabolism of LDL-C and the clearance of LDL-C in the blood; at the same time, it inhibits the synthesis of very low-density lipoprotein (VLDL-C) in the liver, thereby inhibiting the production of low-density lipoprotein (LDL-C).
More
This product is a competitive inhibitor of 3-hydroxy 3-methylglutaryl coenzyme A reductase (HMG-CoA reductase). It reduces the amount of intracellular cholesterol to a certain extent by reversibly inhibiting the activity of HMG-CoA reductase, leading to an increase in the number of low-density lipoprotein (LDL) receptors on the cell surface, thereby enhancing the receptor-mediated catabolism of LDL-C and the clearance of LDL-C in the blood; at the same time, it inhibits the synthesis of very low-density lipoprotein (VLDL-C) in the liver, thereby inhibiting the production of low-density lipoprotein (LDL-C). |
81131-70-6 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Methoxyphenamine hydrochloride |
Beta-adrenergic receptor agonists, which relax bronchial smooth muscle
More
Beta-adrenergic receptor agonists, which relax bronchial smooth muscle |
5588-10-3 | 8 | |
| Aminophylline |
It can relax bronchial smooth muscles and reduce bronchial mucosal congestion and edema
More
It can relax bronchial smooth muscles and reduce bronchial mucosal congestion and edema |
317-34-0 | 10 | |
| NOSCAPINE HYDROCHLORIDE |
Peripheral cough suppressants
More
Peripheral cough suppressants |
912-60-7 | 9 | |
| Chlorphenamine maleate |
H1 receptor blockers, which can counteract the H1-type effects of histamine
More
H1 receptor blockers, which can counteract the H1-type effects of histamine |
113-92-8 | 28 |